Fortrea Holdings (FTRE) Assets Average (2023 - 2026)
Fortrea Holdings' (FTRE) quarterly Assets Average came in at $2.7 billion in Q2 2026, down 9.37% YoY from $3.0 billion in Q2 2025, and little changed on a QoQ basis from $2.7 billion in Q1 2026.
Fortrea Holdings (FTRE) Assets Average (2023 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has 4 years of Assets Average data on file, last reported at $2.7 billion in Q2 2026.
- Quarterly Assets Average fell 9.37% year-over-year to $2.7 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.7 billion (down 9.37% YoY) and the FY2025 annual result came in at $3.1 billion, down 20.44% from the prior year.
- Assets Average was little changed at $2.7 billion in Q2 2026, from $2.7 billion in the prior quarter.
- In the past five years, Assets Average ranged from a high of $4.3 billion in Q3 2023 to a low of $2.7 billion in Q2 2026.
- A 4-year average of $3.4 billion and a median of $3.5 billion in 2024 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2025 — Assets Average decreased 24.65% — and 2026, when it dropped 9.37%.
- Tracing FTRE's Assets Average over 4 years: stood at $4.3 billion in 2023, then slipped by 16.26% to $3.6 billion in 2024, then decreased by 24.65% to $2.7 billion in 2025, then fell by 1.09% to $2.7 billion in 2026.
- The last three Assets Average figures came in at $2.7 billion (Q2 2026), $2.7 billion (Q1 2026), and $2.7 billion (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Fortrea Holdings | 1.66 Bn | 1.49 Bn | 139.20 Mn | 2.70 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.70 Bn |
| Mar 31, 2026 | 2.70 Bn |
| Dec 31, 2025 | 2.73 Bn |
| Sep 30, 2025 | 2.79 Bn |
| Jun 30, 2025 | 2.98 Bn |
| Mar 31, 2025 | 3.35 Bn |
| Dec 31, 2024 | 3.62 Bn |
| Sep 30, 2024 | 3.61 Bn |
| Jun 30, 2024 | 3.90 Bn |
| Mar 31, 2024 | 4.29 Bn |
| Dec 31, 2023 | 4.32 Bn |
| Sep 30, 2023 | 4.34 Bn |